Two-dimensional molecular profiling of multiple myeloma

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ZELENÁ Jana KONEČNÁ Hana ZDRÁHAL Zbyněk ŠEDO Ondrej MORAVCOVÁ Jana RYCOVÁ Marcela KYJOVSKÁ Drahomíra HANÁKOVÁ Božena HÁJEK Roman

Year of publication 2007
Type Appeared in Conference without Proceedings
MU Faculty or unit

Faculty of Medicine

Citation
Description Multiple myeloma (MM) is a B-cell malignancy characterized by proliferation and accumulation of B lymphocytes and plasma cells, secreting monoclonal immunoglobulins, in the bone marrow and, less frequently, at extramedullary sites. Proteome analysis of clinical samples aims at characterizing disease-specific changes in the protein expression profile of an affected cell. Such changes could serve as potential diagnostic markers. Two-dimensional polyacrylamide gel electrophoresis (2-DE) is widely used in comparative studies of protein expression levels. The potential of this method is strongly dependent on good sample preparation, in order to obtain proteomic maps with good reproducibility and resolution. Aims. The aim of this study was to optimize two-dimensional electrophoresis (2-DE) conditions for separation of human myeloma proteins. Methods. We have compared two different solubilization buffers, we also evaluated protein precipitation with ethanol (EtOH) and optimized 2-DE conditions for human myeloma proteins. Myeloma cell line ARH-77 was used to in the pilot study. Proteins from myeloma cell line ARH-77 were separated by 2-DE using a 17 cm pH 3-10 nonlinear immobilized pH gradient strips in the first dimension. Separation in the second-dimension was carried out on the Protean II Cell (Bio-Rad) using a 12% SDS-polyacrylamide gel. Separated proteins were stained with ProteoSilver Plus (Sigma). Spot detection, quantification, and alignment were performed with the PDQuest software (version 7.3.0., Bio-Rad). Results. Two concentrations of the detergent CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) in the solubilization buffer were tested, 2% and 4%. Higher concentration of CHAPS showed a greater ability to solubilize proteins. The most efficient solubilization was obtained with lysis buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 60 mM DTT (dithiothreitol), 0.8% carrier ampholytes and 0.003% BPB (bromphenol blue). About 1448 spots were visualized in the gel using this lysis buffer. Many proteins (206 spots) were lost after the EtOH precipitation, though. Conclusions. Initial extraction and solubilization are key factors of proteomic analysis. The successful solubilization and 2-DE separation of proteins will be valuable tool for further study of the mechanisms of therapy resistance in purified plasma cells of patients with MM and further study of the biomarkers for prediction of progression of MGUS to overt myeloma.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.